The surgical burden score: a novel continuous metric to predict postoperative complications after hepatectomy for hepatocellular carcinoma.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
801 patients, complications occurred in 39.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] SBS, a Pythagorean-based metric combining operative time and aBL, accurately predicts complications. The SBS-based model offers strong predictive utility for risk stratification.
[BACKGROUND] No validated model incorporates surgical parameters for complication risk in hepatocellular carcinoma (HCC) resection.
- p-value p < 0.001
- p-value p = 0.036
- 95% CI 1.113-1.365
- HR 1.231
APA
Akabane M, Kawashima J, et al. (2025). The surgical burden score: a novel continuous metric to predict postoperative complications after hepatectomy for hepatocellular carcinoma.. HPB : the official journal of the International Hepato Pancreato Biliary Association, 27(11), 1445-1454. https://doi.org/10.1016/j.hpb.2025.08.006
MLA
Akabane M, et al.. "The surgical burden score: a novel continuous metric to predict postoperative complications after hepatectomy for hepatocellular carcinoma.." HPB : the official journal of the International Hepato Pancreato Biliary Association, vol. 27, no. 11, 2025, pp. 1445-1454.
PMID
40912956
Abstract
[BACKGROUND] No validated model incorporates surgical parameters for complication risk in hepatocellular carcinoma (HCC) resection. We evaluated a novel Surgical Burden Score (SBS), integrating adjusted blood loss (aBL; mL/kg) and operative time (hours) via a Pythagorean formula, and developed an SBS-based model to predict complications.
[METHODS] Patients undergoing curative-intent hepatectomy for HCC(2000-2023) were identified from an international database. SBS was calculated as SBS=(operative time)+(aBL). Outcomes were any and severe complications (Clavien-Dindo ≥ III). ROC curves and AUCs evaluated performance. A 3:1 training/testing split was used for model development, incorporating SBS plus clinical variables.
[RESULTS] Among 801 patients, complications occurred in 39.1 %, and severe complications in 11.0 %. On multivariable analysis, operative time (HR:1.231; 95%CI:1.113-1.365; p < 0.001) and aBL (HR:1.021; 95%CI:1.002-1.041; p = 0.036) were independent predictors of any complications. SBS(median:6.07 [IQR:4.08-10.07]) outperformed its components (AUC:0.71vs0.67 for operative time and 0.69 for aBL). Stratified SBS groups demonstrated a dose-dependent increase in complications (p < 0.001). The SBS-based model achieved AUCs of 0.73 (training) and 0.76 (testing), outperforming existing models. An online calculator is available (https://makbn.shinyapps.io/SBS_shiny/).
[CONCLUSIONS] SBS, a Pythagorean-based metric combining operative time and aBL, accurately predicts complications. The SBS-based model offers strong predictive utility for risk stratification.
[METHODS] Patients undergoing curative-intent hepatectomy for HCC(2000-2023) were identified from an international database. SBS was calculated as SBS=(operative time)+(aBL). Outcomes were any and severe complications (Clavien-Dindo ≥ III). ROC curves and AUCs evaluated performance. A 3:1 training/testing split was used for model development, incorporating SBS plus clinical variables.
[RESULTS] Among 801 patients, complications occurred in 39.1 %, and severe complications in 11.0 %. On multivariable analysis, operative time (HR:1.231; 95%CI:1.113-1.365; p < 0.001) and aBL (HR:1.021; 95%CI:1.002-1.041; p = 0.036) were independent predictors of any complications. SBS(median:6.07 [IQR:4.08-10.07]) outperformed its components (AUC:0.71vs0.67 for operative time and 0.69 for aBL). Stratified SBS groups demonstrated a dose-dependent increase in complications (p < 0.001). The SBS-based model achieved AUCs of 0.73 (training) and 0.76 (testing), outperforming existing models. An online calculator is available (https://makbn.shinyapps.io/SBS_shiny/).
[CONCLUSIONS] SBS, a Pythagorean-based metric combining operative time and aBL, accurately predicts complications. The SBS-based model offers strong predictive utility for risk stratification.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Minimally invasive surgery for hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk.
- Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC.
- Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy.
- Distinct patterns of late recurrence in long-term hepatocellular carcinoma survivors.
- International validation of a natural-killer-cell-based model to predict recurrence-free survival in hepatocellular carcinoma.